Related references
Note: Only part of the references are listed.Antigen-loaded exosomes alone induce Th1-type memory through a B cell-dependent mechanism
Khaleda Rahman Qazi et al.
BLOOD (2009)
Human tumor-derived exosomes down-modulate NKG2D expression
Aled Clayton et al.
JOURNAL OF IMMUNOLOGY (2008)
Exosomes as a short-range mechanism to spread alloantigen between dendiritic cells during T cell allorecognition
Angela Montecalvo et al.
JOURNAL OF IMMUNOLOGY (2008)
Exosome function: From tumor immunology to pathogen biology
Jeffrey S. Schorey et al.
TRAFFIC (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL
Lea Luketic et al.
JOURNAL OF IMMUNOLOGY (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells
Chiara Napoletano et al.
CANCER RESEARCH (2007)
Human tumor-derived exosomes selectively impair lymphocyte responses to interieukin-2
Aled Clayton et al.
CANCER RESEARCH (2007)
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma
Malcolm S. Mitchell et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells
Danilo Millimaggi et al.
NEOPLASIA (2007)
Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity
Siguo Hao et al.
IMMUNOLOGY (2007)
Tumor-released microvesicles as vehicles of immunosuppression
Roberta Valenti et al.
CANCER RESEARCH (2007)
Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions
Rita Nanda
REVIEWS ON RECENT CLINICAL TRIALS (2007)
Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells
Yunshan Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Prospects for exosomes in immunotherapy of cancer
G. Mignot et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Priming of T cells by exogenous antigen cross-presented on MHC class I molecules
LJ Shen et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients
GE Peoples et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
HER-2:: A biomarker at the crossroads of breast cancer immunotherapy and molecular medicine
SM Pupa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
B Escudier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Exosomes as potent cell-free peptide-based vaccine.: I.: Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells
F André et al.
JOURNAL OF IMMUNOLOGY (2004)
Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells
AE Morelli et al.
BLOOD (2004)
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
RF Rousseau et al.
BLOOD (2003)
Production and characterization of clinical grade exosomes derived from dendritic cells
HG Lamparski et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Malignant effusions and immunogenic tumour-derived exosomes
F Andre et al.
LANCET (2002)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells
EM Hiltbold et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
